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Abstract
Background: Wnt/b-catenin signaling is an important regulator of differentiation and morphogenesis that can also control
stem cell fates. Our group has developed an efficient protocol to generate cardiomyocytes from human embryonic stem
(ES) cells via induction with activin A and BMP4.
Methodology/Principal Findings: We tested the hypothesis that Wnt/b-catenin signals control both early mesoderm
induction and later cardiac differentiation in this system. Addition of exogenous Wnt3a at the time of induction enhanced
cardiac differentiation, while early inhibition of endogenous Wnt/b-catenin signaling with Dkk1 inhibited cardiac
differentiation, as indicated by quantitative RT-PCR analysis for b-myosin heavy chain (b-MHC), cardiac troponin T (cTnT),
Nkx2.5, and flow cytometry analysis for sarcomeric myosin heavy chain (sMHC). Conversely, late antagonism of
endogenously produced Wnts enhanced cardiogenesis, indicating a biphasic role for the pathway in human cardiac
differentiation. Using quantitative RT-PCR, we show that canonical Wnt ligand expression is induced by activin A/BMP4
treatment, and the extent of early Wnt ligand expression can predict the subsequent efficiency of cardiogenesis.
Measurement of Brachyury expression showed that addition of Wnt3a enhances mesoderm induction, whereas blockade of
endogenously produced Wnts markedly inhibits mesoderm formation. Finally, we show that Wnt/b-catenin signaling is
required for Smad1 activation by BMP4.
Conclusions/Significance: Our data indicate that induction of mesoderm and subsequent cardiac differentiation from
human ES cells requires fine-tuned cross talk between activin A/BMP4 and Wnt/b-catenin pathways. Controlling these
pathways permits efficient generation of cardiomyocytes for basic studies or cardiac repair applications.
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Introduction
Heart failure is a leading cause of death among all patient
populations, in large part due to the heart’s limited ability for self-
repair. Thus, a cell-based regenerative strategy for cardiac repair
would be highly attractive. A variety of cell sources have been
identified as candidates for myocardial repair, including skeletal
myoblasts [1], various bone marrow stem cells [2], resident cardiac
progenitors [3], and pluripotent cells such as embryonic stem (ES)
cells or induced pluripotent stem (iPS) cells [4]. Human ES cells are
capable of differentiation into definitive cardiomyocytes, as indicated
by appropriate contractile function, action potentials and electrome-
chanical coupling (the cells beat synchronously in culture), as well as
ultrastructural morphology and gene expression [5,6,7].
Significant progress has recently been made toward increasing
the efficiency of human ES cell differentiation into cardiomyocytes
by harnessing pathways learned from developmental biology. Our
group has demonstrated that sequential treatment with activin A
and BMP4 results in enhanced generation of mesoderm followed
by induction toward a cardiac fate, with 10–50% of cells
differentiating into definitive cardiomyocytes [8,9]. However,
before these cells can be used for therapy in humans, it will be
necessary to understand the signaling pathways that affect the
differentiation and maturation of ES cells and their progeny. Thus,
we set out to determine the role of Wnt/b-catenin signaling in
human ES cells undergoing cardiac directed differentiation with
activin A/BMP4.
The precise role of Wnt pathways in cardiovascular differen-
tiation remains unclear. Early studies in chick and frog embryos
showed that canonical Wnt antagonists, crescent and Dikkopf
(Dkk), induce cardiac gene expression while Wnt/b-catenin
signaling inhibits cardiac differentiation [10,11]. However, Wnt/
b-catenin signaling was shown to enhance cardiac differentiation
in pluripotent mouse P19CL6 cells [12]. Recent work from our
group and others has partially resolved this discrepancy by
showing that canonical Wnt/b-catenin signaling has a biphasic
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signaling pathways in cardiogenesis is potent, complex and highly
context-dependent.
We hypothesized that Wnt/b-catenin signaling would be an
important modulator of cardiac differentiation in human ES cells.
Thus, we examined the role of canonical Wnt signaling in the
context of activin A/BMP4 cardiac directed differentiation. We
found that the expression of several canonical Wnt ligands was
induced by activin A/BMP4 during the early stages of differen-
tiation. Prior to mesoderm specification, addition of exogenous
canonical Wnt ligand enhanced cardiac differentiation while
inhibition of endogenous canonical Wnt signaling reduced the
efficiency of cardiac differentiation. Furthermore, inhibition of
canonical Wnt signaling at later stages of differentiation enhanced
cardiogenesis. Finally, we demonstrated cross-talk between Wnt
and BMP pathways at the level of Smad1 phosphorylation. Thus,
interplay between Wnt and TGFb family signaling controls
human ES cell differentiation to cardiomyocytes and can be
exploited for efficient directed differentiation.
Results
Wnt/b-catenin Signaling Regulates Cardiac
Differentiation
In an effort to improve the efficiency of cardiac differentiation
from human ES cells, our group recently developed a directed
differentiation protocol that involves sequential treatment with
activin A and BMP4 [8]. This combination of factors results in
cultures that typically contain 10–50% cardiomyocytes and
spontaneously contract. To examine the role of Wnt/b-catenin
signaling in this system, we treated human ES cells undergoing
directed differentiation with Wnt3a, a canonical Wnt ligand, or
Dkk1, a canonical Wnt inhibitor. Using quantitative RT-PCR, we
measured expression of cardiac-specific genes, including b-myosin
heavy chain (b-MHC, aka MYH7), a contractile protein, cardiac
troponin T (cTnT), a regulator of cardiac muscle contraction, and
Nkx2.5, a cardiac transcription factor, on day 14 of differentiation.
Using the standard activin A/BMP4 directed differentiation
protocol, we found over a 300-fold increase in b-MHC relative
to cultures treated with medium alone without cytokines (p,0.01)
(Figure 1A). Addition of Wnt3a enhanced this effect (about 400-
fold induction over controls) while addition of Dkk1 drastically
reduced cardiac differentiation (only 85-fold induction over
controls). Similar results were seen for cTnT and Nkx2.5.I n
addition, we used flow cytometry to quantify the proportion of
cells expressing sarcomeric myosin heavy chain (sMHC) in six
independent experiments. By 21 days of differentiation, 33% of
activin A + BMP4 treated cultures were sMHC positive. Of note,
we have verified the absence of skeletal muscle differentiation, the
only other cell type to express this epitope. Exogenous Wnt3a
increased the proportion of sMHC positive cells to 49% while
inhibition of canonical Wnt signaling with Dkk1 reduced the
population to 7% (Figure 1B). While there was variation in the
exact percentage of sMHC expressing cells between experiments,
the addition of Wnt3a or Dkk1 consistently enhanced or inhibited
cardiac differentiation relative to standard activin A/BMP4
treatment, respectively. The marked inhibition of cardiac
differentiation by Dkk1 indicates that endogenously produced
Wnt signals are required in the early stages of differentiation
induced by exogenous activin A and BMP4.
To determine if other mesodermal lineages emerge using activin
A/BMP4 directed differentiation, we performed quantitative RT-
PCR for SM22a and VE-cadherin, markers of smooth muscle and
endothelium, respectively (Figure S1). Using the standard activin
A/BMP4 treatment, we found only about a 3-fold increase in
SM22a and a 5-fold increase in VE-cadherin. Enhancing canonical
Wnt signaling using exogenous Wnt3a or blocking endogenous
canonical Wnt signaling with Dkk1 had no significant effect on
expression of either of these markers. Taken together, these data
suggest that our directed differentiation system highly enriches the
cardiomyocyte yield, and manipulation of Wnt/b-catenin signal-
ing in this context does not alter differentiation of smooth muscle
or endothelial lineages.
Effects of Wnt/b-catenin Signaling on Cardiac
Differentiation are Stage-Specific
We have previously shown that inhibition of Wnt/b-catenin
signaling after mesoderm specification can enhance cardiac
differentiation in mouse ES cells [13]. Thus, we hypothesized
that human ES cells would also show increased cardiac
differentiation in response to inhibition of Wnt/b-catenin signaling
during later stages of differentiation. Dkk1 was added to human
ES cells undergoing directed differentiation for 4–10 days
following BMP4 treatment (days 5–11 of differentiation). Quan-
titative RT-PCR showed a 70% increase in b-MHC expression in
cultures treated with activin A/BMP4 plus late Dkk1 compared to
cultures treated with activin A/BMP4 only (Figure 1C). Thus,
inhibition of canonical Wnt signaling can enhance cardiac
differentiation in human ES cells when Dkk1 is added later in
differentiation, after definitive mesoderm has formed.
Canonical Wnts are Expressed During Early activin A/
BMP4-Mediated Cardiac Differentiation
The observation that Dkk1 inhibits cardiac differentiation when
added at day 1 points to the presence of endogenous canonical Wnt
activity at this stage of differentiation. Thus, we next studied
expression of canonical Wnt ligands during early directed differen-
tiation of H7 human ES cells using quantitative RT-PCR. Key
canonical Wnts, including Wnt1, Wnt3a,a n dWnt8a were up-
regulated during this time (Figure 2A). Wnt1 was induced 8–10 fold
on day 1 and decreased thereafter. Wnt3a was induced ,600-fold on
d a y2a n dre ma i n e dh i g ho nd a y3 .Wnt8awasinduced 30-foldonday
2 and 120-fold on day 3. These studies confirm the induction of
endogenous canonical Wnt ligands during cardiac differentiation
directed by activin A and BMP4, and reveal that the various
canonical Wnt ligands are differentially upregulated.
We have observed that the activin A/BMP4 directed differen-
tiation protocol is not always successful. For reasons that are not
yet clear, some runs yield less than 5–10% cardiomyocytes.
Interestingly, a different pattern of early canonical Wnt expression
was observed in cultures of H7 human ES cells that ultimately
yielded low numbers of cardiomyocytes (Figure 2A). The most
dramatic differences in expression levels were observed for Wnt3a
and Wnt8a. Wnt3a expression peaked at 11.6 fold at day 3 of
differentiation in cultures containing low cardiac yield. This is in
stark contrast to the ,600-fold peak observed in cultures with high
cardiomyocyte yields. Wnt8a expression increased to 5.1 fold by
day 1 and then dropped back down to baseline levels, in contrast
to the 120-fold induction in high yield runs. We also examined
canonical Wnt ligand expression during differentiation of H1
human ES cells, which are less cardiogenic than H7 cells, and
generate cultures that are ,1% cardiomyocytes in our hands (data
not shown). In H1 cells, Wnt1, Wnt3a, and Wnt8a were not
significantly upregulated during mesoderm specification following
treatment with activin A/BMP4. This suggests that the pattern of
canonical Wnt expression during early differentiation correlates
with the efficiency of cardiogenesis.
Wnt Regulates Cardiomyogenesis
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cultures that differentiate poorly, we administered exogenous
Wnt3a or Dkk1 during the early stages of differentiation, as in the
previously described experiments. Interestingly, we found that
addition of Wnt3a can rescue cultures of H7 human ES cells that
demonstrated inefficient cardiac differentiation in response to
activin A/BMP4 (Figure 2B). Cultures treated with activin A/
BMP4 were only 4% sMHC+, whereas the early addition of
exogenous Wnt3a increased the cardiomyocytes population to
27%. Inhibition of Wnt/b-catenin signaling with Dkk1 resulted in
cultures that were 3% sMHC+. This effect is less dramatic than
what was observed in the previously mentioned experiments, likely
due to the decrease in endogenous canonical Wnt signaling in
these cultures. Taken together, these studies show that Wnt/b-
Figure 1. Early Wnt/b-catenin signaling enhances cardiac differentiation. (A) Quantitative RT-PCR on day 14 of differentiation shows
induction of b-MHC, cTnT and Nkx2.5 expression by activin A/BMP4 is attenuated with Dkk1. Data are presented as mean fold expression
normalized to HPRT relative to control cells. (B) Flow cytometry analysis for sarcomeric myosin heavy chain (sMHC) on day 21 of differentiation
shows enhanced cardiac differentiation with addition of exogenous Wnt3a and decreased cardiac differentiation with Dkk1. (C) Late addition of
Dkk1 enhanced day 14 b-MHC expression relative to samples treated with activin A/BMP4 only. Data are presented as mean fold expression
normalized to HPRT relative to control cells. *p,0.05 relative to control, **p,0.01 relative to control, {p,0.05 relative to activin A/BMP4, {p,0.01
relative to activin A/BMP4.
doi:10.1371/journal.pone.0011134.g001
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e11134Figure 2. Canonical Wnt expression during mesoderm specification correlates with the efficiency of cardiac differentiation.
Quantitative RT-PCR for canonical Wnt ligands Wnt1, Wnt3a and Wnt8a. Data are presented as mean fold expression normalized to HPRT relative to
undifferentiated cells. (A) Representative of cultures of H7 hES cells that showed efficient and inefficient directed differentiation to cardiomyocytes
(.25% and ,5% sMHC+, respectively), as well as H1 hES cells that are poorly cardiogenic. (B) Cultures that routinely generated ,5% cardiomyocytes
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ES cells and absence of endogenously produced Wnts correlates
with poor cardiac differentiation.
Wnt/b-catenin Signaling Regulates Mesoderm
Specification
As a first step to elucidate the mechanism by which early Wnt/
b-catenin signals regulate cardiogenesis in human ES cells, we
collected RNA at early time points to measure the induction of
germ-layer specific markers, namely Brachyury T (mesoderm), Sox1
(ectoderm), and FoxA2 (endoderm). We have previously shown that
in our directed differentiation system, Brachyury expression peaks
around two days after addition of activin A [9]. Thus, we used
quantitative RT-PCR to measure Brachyury expression on day 2 of
differentiation in cells treated with activin A/BMP4 (standard
directed differentiation) compared with cells treated with activin
A/BMP4 plus exogenous Wnt3a or Dkk1 to block endogenous
canonical Wnt signaling. Samples collected on day 0, prior to
induction with activin A, were used to determine baseline
expression. While addition of Wnt3a enhanced Brachyury expres-
sion, addition of Dkk1 greatly attenuated mesoderm induction
normally seen with our directed differentiation protocol (Figure 3).
These data suggest that endogenous canonical Wnts are necessary
for mesoderm formation and subsequent cardiogenesis in human
ES cells. Cells treated with control medium showed the highest
level of Sox1 expression, consistent with the observation that ES
cells spontaneously differentiate into ectoderm in the absence of
factors mimicking the primitive streak environment. Although
exogenous Wnt3a had no effect on FoxA2 expression, Wnt
antagonism with Dkk1 enhanced expression of this endoderm
marker.
To investigate the effects of canonical Wnt signaling on cell
death and proliferation during this stage of differentiation, we
performed cell counts, annexin V staining for apoptotic cells, and
propidium iodide staining for cell cycle analysis (Figure S2).
Cultures treated with activin A/BMP4 had roughly 40% fewer
adherent cells than non-treated controls on day 2 of differentiation
in association with an increase in non-adherent cells. Wnt3a or
Dkk1 treatment did not significantly alter cell number. Among the
adherent cell population, roughly 15% of the cells were annexin V
positive in the control and activin A/BMP4 treated groups. This
increased to 20% with Wnt3a addition and 30% with Dkk1. In
addition, there were no significant changes in cell proliferation
between treatment groups, with all cultures showing roughly 50%
of cells in G1 phase, 25–30% in S phase, and 20% in G2/M
phase. Overall, these effects are mild compared to the drastic
effects on Brachyury and cardiac gene expression, suggesting that
the primary role of Wnt/b-catenin signaling in this context is in
driving differentiation rather than influencing cell death or
proliferation. Interestingly, cell fractionation showed no increase
in nuclear localization of b-catenin in undifferentiated (day 0) vs.
differentiated (day 2) cultures (Figure S3), suggesting regulation
distal to nuclear translocation.
Canonical Wnt Signaling Regulates Smad Activation
We next explored intracellular signaling pathways to determine
how activin A/BMP4 signaling synergizes with canonical Wnt
signaling to drive mesoderm and ultimately cardiac differentiation.
Using Western blotting, we monitored Smad1 or Smad2
activation by probing for phosphorylated Smads. We found that
Dkk1 reduced activation of Smad1 in response to BMP4
stimulation (Figure 4), suggesting that endogenous canonical
Wnt signaling enhances phospho-Smad1 production or stability
in the context of the activin A/BMP4 cardiac directed
differentiation system.
Discussion
Wnt signaling plays a key role in the differentiation and
morphogenesis of many cell types and tissues. However, the effects
of Wnt/b-catenin signaling on cardiac differentiation have been
difficult to pinpoint due to conflicting data. While studies in frog
and chick embryos suggested that Wnt/b-catenin signaling
suppressed cardiac differentiation, evidence from mouse P19CL6
teratocarcinoma cells indicated a positive role for Wnt/b-catenin
signaling in cardiogenesis [10,11,12]. Our group and others
addressed these discrepancies by showing that Wnt/b-catenin
signaling has a biphasic effect, whereby cardiac differentiation is
enhanced prior to gastrulation and inhibited after gastrulation
[13,14,15]. By using transgenic zebrafish embryos, we showed that
Wnt/b-catenin signaling prior to gastrulation is necessary for
mesoderm induction but rapidly switches to an anti-cardiogenic
effect after gastrulation [13]. Similarly, in mouse ES cells, early
activation of Wnt/b-catenin signaling enhances mesoderm and
cardiac induction, as indicated by increased Brachyury T and a-
myosin heavy chain (a-MHC) expression, respectively. However,
activation of the same pathway inhibits cardiac differentiation at
later timepoints, likely by directing cells towards alternative
mesodermal fates [13]. Interestingly, it was recently shown that
in mouse ES cells, Dkk1 expression is activated by MesP1,
suggesting that this transcription factor, expressed in pre-cardiac
mesoderm, may promote cardiac differentiation by inhibiting
Wnt/b-catenin signals [16].
In the present study, we showed that Wnt/b-catenin signaling
modulates activin A/BMP4-mediated cardiac differentiation of
human ES cells. During early stages of differentiation, addition of
exogenous Wnt3a enhanced cardiac differentiation while inhibi-
tion of canonical Wnt signaling with Dkk1 decreased cardiogen-
esis. These data indicate that the ability of activin A/BMP4 to
induce cardiac differentiation depends on endogenous Wnt
signaling. Indeed, induction of multiple canonical Wnt ligands
can be observed during early directed differentiation, which leads
to high cardiomyocyte yields. On the other hand, addition of Dkk1
at later stages of differentiation increased cardiogenesis, showing
that Wnt/b-catenin signaling has a biphasic effect in human ES
cells, similar to our previous findings in zebrafish embryos and
mouse ES cells [13]. Thus, these studies show that Wnt/b-catenin
and activin A/BMP4 signaling interact to regulate cardiac
differentiation in human ES cells.
Recent work from other groups shows that activin/BMP
signaling, along with canonical Wnts, modulates primitive streak
and subsequent germ layer differentiation in mouse and human
ES cells [17,18,19]. Our data support these previous findings,
showing that activin A/BMP4 induction of the mesoderm-specific
transcription factor Brachyury is enhanced by addition of exogenous
Wnt3a and repressed by addition of Dkk1. The data presented
here suggest that canonical Wnt signaling is a key regulator of
mesoderm specification and subsequent cardiogenesis in human
ES cells undergoing directed differentiation with activin A/BMP4.
were treated with Wnt3a or Dkk1 in addition to activin A and BMP4. After 17 days of differentiation following activin A treatment, cells were stained
for sMHC. Exogenous Wnt3a partially rescued inefficient cardiac differentiation.
doi:10.1371/journal.pone.0011134.g002
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during the first three days of differentiation was drastically
different in H7 cultures that ultimately showed .25% cardiomy-
ocytes compared to H7 and H1 cultures that generate only 5–10%
or ,1% cardiomyocytes, respectively. Furthermore, addition of
exogenous Wnt3a was able to rescue inefficient cardiac directed
differentiation in some cases, increasing the percent sMHC+ cells
by more than 6-fold (Figure 2). These data indicate that variations
in endogenous signaling pathways could account for much of the
variation in efficiency encountered with this directed differentia-
tion protocol.
Our data also show that Wnt/b-catenin signaling modulates
signaling events downstream of BMP4. Activin A and BMP4 are
members of the TGF-b superfamily. Activin A signals through C-
terminal phosphorylation and subsequent activation of Smad2
while BMP4 signaling results in similar activation of Smad1. These
phosphorylated Smads interact with Smad4 and enter the nucleus
to serve as transcription factors. It has been suggested that
canonical Wnt signaling stabilizes Smads by inhibiting GSK3,
which has been shown to phosphorylate Smad1 at a site, distinct
from that phosphorylated by the BMP receptor, which targets it
for ubiquitination and subsequent degradation [20]. Indeed, we
show that the ability of BMP4 to induce receptor-mediated
phosphorylation of Smad1 is dramatically reduced in the presence
of Dkk1. In contrast, Wnt3a did not enhance Smad2 activation
following activin A treatment (data not shown). Thus, the cross-
talk between canonical Wnt and TGF-b signaling pathways likely
involves direct interactions between downstream signaling effec-
tors in addition to co-regulation of target genes.
We have shown the importance of activin A, BMP4 and Wnt/
b-catenin signaling in driving cardiac differentiation in human ES
cells. As in development, many other signaling pathways are likely
modulating cardiogenesis in this system. It will be essential to
address the interactions between these various pathways to
maximize cardiac differentiation from human ES cells. This will
greatly improve our understanding of human cardiac development
and enhance our ability to produce cardiomyocytes for future
basic studies and cardiac repair applications.
Materials and Methods
Maintenance of Human Embryonic Stem Cells
H7 and H1 human ES cells were maintained as previously
described [21]. In brief, cells were grown on Matrigel-coated
plates in mouse embryonic fibroblast-conditioned medium (MEF-
CM) supplemented with basic fibroblast growth factor (bFGF) at a
concentration of 8 ng/mL. Cells were passaged every 4–6 days
using collagenase IV (Gibco) to detach the cells from the Matrigel-
coated plates.
Cardiac Directed Differentiation
For cardiac directed differentiation, undifferentiated human ES
cells were replated and allowed to grow to confluence as high-
density monolayers on 24-well plates. Cells were then treated with
100 ng/mL recombinant activin A in RPMI medium (Invitrogen)
supplemented with B27 (Invitrogen) for 24 hours followed by
10 ng/mL human recombinant BMP4 for 4 days. RPMI-B27
medium was replaced every 2 days thereafter. When applicable,
100 ng/mL recombinant Wnt3a was added with activin A or
200 ng/mL recombinant Dkk1 was added with BMP4. Dkk1 lot
activity was verified using HEK cells expressing luciferase driven
by a beta-catenin activated reporter (BAR) [22]. Recombinant
mouse Wnt3a was purchased from Millipore. Recombinant mouse
activin A, human BMP4 and human Dkk1 were purchased from
R+D Systems.
RT-PCR
Total RNA was isolated using the RNeasy Miniprep kit
(Qiagen). First-strand cDNA was synthesized from 1 mg total
RNA using the Superscript II enzyme kit (Invitrogen) and random
hexamer primers. Quantitative PCR was performed using SYBR
Green PCR kit on a 7900HT Fast-Real-Time PCR System
(Applied Biosystems). The copy number for each transcript is
expressed relative to that of HPRT, which is used as an internal
control, and normalized to a value of 1.0 for undifferentiated cells
or control cells not treated with exogenous cytokines.
Figure 3. Wnt/b-catenin signaling enhances mesoderm induc-
tion. Quantitative RT-PCR analysis on day 2 of differentiation shows
induction of Brachyury (mesoderm), FoxA2 (endoderm), and Sox1
(ectoderm). Brachyury expression induced by activin A/BMP4 was
enhanced by Wnt3a and reduced by Dkk1. Data are presented as mean
fold expression normalized to HPRT relative to undifferentiated cells +
SEM. *p,0.05 relative to control, **p,0.01 relative to control, {p,0.05
relative to activin A/BMP4, {p,0.01 relative to activin A/BMP4.
doi:10.1371/journal.pone.0011134.g003
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For analysis of cardiac differentiation, cell cultures were
harvested with TrypLE (Invitrogen) plus 100 U/mL DNase
(Invitrogen) and fixed in cold methanol. Cells were incubated
with purified anti-sarcomeric myosin heavy chain primary
antibody (MF20, Developmental Studies Hybridoma Bank,
1:100) overnight at 4uC followed by PE-conjugated goat anti-
mouse secondary antibody (Jackson, 1:150) for one hour at room
temperature. Analysis was performed using an FC500 machine
(BD).
For apoptosis analysis, dissociated cells were stained with
annexin V-APC antibody (eBioscience) according to the manu-
facturer’s instructions. Briefly, cells were incubated in 100 uL
annexin binding buffer with 5 uL annexin V-APC antibody for 15
minutes at room temperature, washed, and analyzed.
Cell cycle analysis was performed by fixing cells in cold ethanol
followed by incubation with propidium iodide (40 ug/mL,
Molecular Probes) and RNase (100 ug/mL, Macherey-Nagel) for
one hour at 37uC. FlowJo software was used to determine the
percent of cells in G1, S, or G2/M phases.
Western Blotting
Cells were lysed with sample buffer containing Tris-HCl
(50 mM), SDS (1%), glycerol (10%), complete protease inhibitor
(Roche), and phosphatase inhibitors (sodium fluoride, sodium
pyrophosphate, sodium orthovanadate, 1 mM each). Samples
were sheared using a 20 gauge needle. For samples requiring
separation of cytoplasmic and nuclear proteins, we utilized the
NE-PER kit (Pierce) according to the manufacturer’s instructions.
Protein concentration was determined using a bicinchoninic acid
assay (BCA) (Pierce). Samples were boiled, and 10 mg total protein
was loaded into 10% acrylamide gels. Protein was transferred to
PVDF membranes. Blot were blocked in 0.5% milk in Tris-
buffered saline plus 0.1% Tween, incubated in primary antibody
for 10 minutes, rinse with TBS-Tween three times, incubated in
secondary antibody for 10 minutes, and rinsed with TBS-Tween
three using a SNAP id apparatus (Millipore). Visualization was
accomplished using chemiluminescence (Pierce). Primary antibod-
ies used were: anti-Smad1 (Cell Signaling, 1:1000), anti-phos-
phoSmad1 (Cell Signaling, 1:1000), anti-b-catenin (Abcam,
1:1000), anti-b-actin (Abcam, 1:1500), anti-b-tubulin (Cell Signal-
ing, 1:250). Secondary antibodies used were HRP-conjugated goat
anti-rabbit or goat anti-mouse (Jackson, 1:5000). Densitometry
analysis was performed using Image J software.
Supporting Information
Figure S1 Early Wnt/b-catenin signaling does not affect other
cardiovascular lineages during cardiac directed differentiation.
Quantitative RT-PCR on day 14 of differentiation shows a small
induction of SM22a and VE-cadherin by activin A/BMP4
treatment. These effects are not significantly altered by treatment
with either Wnt3a or Dkk1.
Found at: doi:10.1371/journal.pone.0011134.s001 (0.67 MB TIF)
Figure S2 Early Wnt/b-catenin signaling has a modest effect on
apoptosis and proliferation. (A) Shown are both adherent and non-
adherent cell counts from 3 wells of a 24-well plate for each
treatment group. (B) Samples were analyzed by flow cytometry for
Figure 4. Wnt/b-catenin signaling regulates Smad1 activation. High-density undifferentiated human ES cells were treated with activin A for
24 hours followed by BMP4 or BMP4 plus Dkk1. Lane marked as ‘‘pre’’ indicates cells collected prior to cytokine treatment. Western blot shows
probing for C-terminal phosphorylated Smad1 (p-Smad1) and total Smad1 at 30 m, 1 h, 2 h and 3 h following BMP4. Densitometry data are
presented as phosphorylated Smad1 normalized to total Smad1 relative to pretreated cultures. Treatment with BMP4 increased phosphorylation of
Smad1, which was reduced by inhibition of canonical Wnt signaling with Dkk1.
doi:10.1371/journal.pone.0011134.g004
Wnt Regulates Cardiomyogenesis
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11134annexin V to identify apoptotic cells. (C) Samples were incubated
with propidium iodide and analyzed by flow cytometry for DNA
content.
Found at: doi:10.1371/journal.pone.0011134.s002 (0.75 MB TIF)
Figure S3 b-catenin is present in the nuclei of undifferentiated
ES cells and early differentiated cells. Shown are Western blots of
cytoplasmic and nuclear fractions from day 0 (undifferentiated)
and day 2 (mesoderm) cells. Probing for b-catenin shows robust
expression in both the cytoplasmic and nuclear fractions at both
timepoints. Also shown is b-actin as a loading control and b-
tubulin to verify minimal contamination of cytoplasmic contents in
the nuclear fractions. C=cytoplasmic fraction, N=nuclear
fraction.
Found at: doi:10.1371/journal.pone.0011134.s003 (0.11 MB TIF)
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